Exagen Inc. (NASDAQ: XGN) reported Q1 EPS of ($0.44), $0.24 better than the analyst estimate of ($0.68). Revenue for the quarter came in at $11.2 million versus the consensus estimate of $9.4 million.

For earnings history and earnings-related data on Exagen Inc. (XGN) click here.